Can Sitagliptin enhance the therapeutic efficacy of GLP-1 receptor agonists when used in combination therapy?
Sunil JoshiExplorer
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can Sitagliptin enhance the therapeutic efficacy of GLP-1 receptor agonists when used in combination therapy?
Sitagliptin, a DPP-4 inhibitor, may enhance GLP-1 levels, potentially improving the efficacy of GLP-1 receptor agonists in managing type 2 diabetes.